NEW YORK (GenomeWeb) – A clinical cancer whole-exome and transcriptome sequencing test recently launched by Columbia University's Laboratory of Personalized Genomic Medicine promises to impact the treatment of cancer patients.
The new test was developed as part of a wider effort to incorporate personalized medicine approaches into Columbia's pediatric oncology program, according to Andrew Kung, chief of the division of pediatric hematology, oncology, and stem cell transplantation.